This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
November 05, 2020
BONESUPPORT HOLDING AB (publ) – Publishes Q3 2020 Interim report
November 05, 2020
Targovax ASA: third quarter 2020 results
November 05, 2020
Aprea Therapeutics Reports Third Quarter 2020 Financial Results and Provides Update on Business Operations
November 04, 2020
Oncopeptides Announces that New Data for Melflufen is Accepted for Presentation at the Annual American Society of Hematology Meeting
November 04, 2020
Correction notice of press release – Q3 2020 Interim Report – ZUBSOLV® guiding 2020
November 04, 2020
Orexo Interim Report Q3 2020
November 03, 2020
Vicore announces changes in management team
November 03, 2020
GenSight Biologics reports validation of LUMEVOQ® Marketing Authorisation Application (MAA) by European Medicines Agency
November 03, 2020
Q3 2020 General Market Overview
November 02, 2020
Pulmonx Announces Additional 16 Million Covered Lives for The Zephyr® Valve, a Minimally Invasive Treatment Option for Severe Emphysema (COPD)